Literature DB >> 7614989

The interaction of beta 2-microglobulin (beta 2m) with mouse class I major histocompatibility antigens and its ability to support peptide binding. A comparison of human and mouse beta 2m.

L O Pedersen1, A Stryhn, T L Holter, M Etzerodt, J Gerwien, M H Nissen, H C Thøgersen, S Buus.   

Abstract

The function of major histocompatibility complex (MHC) class I molecules is to sample peptides derived from intracellular proteins and to present these peptides to CD8+ cytotoxic T lymphocytes. In this paper, biochemical assays addressing MHC class I binding of both peptide and beta 2-microglobulin (beta 2m) have been used to examine the assembly of the trimolecular MHC class I/beta 2m/peptide complex. Recombinant human beta 2m and mouse beta 2ma have been generated to compare the binding of the two beta 2m to mouse class I. It is frequently assumed that human beta 2m binds to mouse class I heavy chain with a much higher affinity than mouse beta 2m itself. We find that human beta 2m only binds to mouse class I heavy chain with slightly (about 3-fold) higher affinity than mouse beta 2m. In addition, we compared the effect of the two beta 2m upon peptide binding to mouse class I. The ability of human beta 2m to support peptide binding correlated well with its ability to saturate mouse class I heavy chains. Surprisingly, mouse beta 2m only facilitated peptide binding when mouse beta 2m was used in excess (about 20-fold) of what was needed to saturate the class I heavy chains. The inefficiency of mouse beta 2m to support peptide binding could not be attributed to a reduced affinity of mouse beta 2m/MHC class I complexes for peptides or to a reduction in the fraction of mouse beta 2m/MHC class I molecules participating in peptide binding. We have previously shown that only a minor fraction of class I molecules are involved in peptide binding, whereas most of class I molecules are involved in beta 2m binding. We propose that mouse beta 2m interacts with the minor peptide binding (i.e. the "empty") fraction with a lower affinity than human beta 2m does, whereas mouse and human beta 2m interact with the major peptide-occupied fraction with almost similar affinities. This would explain why mouse beta 2m is less efficient than human beta 2m in generating the peptide binding moiety, and identifies the empty MHC class I heavy chain as the molecule that binds human beta 2m preferentially.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7614989     DOI: 10.1002/eji.1830250621

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  21 in total

1.  A novel system for continuous protein refolding and on-line capture by expanded bed adsorption.

Authors:  Henrik Ferré; Emmanuel Ruffet; Lise-Lotte B Nielsen; Mogens Holst Nissen; Timothy J Hobley; Owen R T Thomas; Søren Buus
Journal:  Protein Sci       Date:  2005-08       Impact factor: 6.725

2.  Structure of HLA-A*1101 in complex with a hepatitis B peptide homologue.

Authors:  Thomas Blicher; Jette Sandholm Kastrup; Lars Østergaard Pedersen; Søren Buus; Michael Gajhede
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2006-11-04

3.  Recombinant chymosin used for exact and complete removal of a prochymosin derived fusion tag releasing intact native target protein.

Authors:  Sune F L Justesen; Kasper Lamberth; Lise-Lotte B Nielsen; Claus Schafer-Nielsen; Søren Buus
Journal:  Protein Sci       Date:  2009-05       Impact factor: 6.725

4.  Adapter-mediated substrate selection for endoplasmic reticulum-associated degradation.

Authors:  Kathleen Corcoran; Xiaoli Wang; Lonnie Lybarger
Journal:  J Biol Chem       Date:  2009-04-14       Impact factor: 5.157

5.  Stability screening of arrays of major histocompatibility complexes on combinatorially encoded flow cytometry beads.

Authors:  Shi Ling Chew; Ming Yan Or; Cynthia Xin Lei Chang; Adam J Gehring; Antonio Bertoletti; Gijsbert M Grotenbreg
Journal:  J Biol Chem       Date:  2011-06-16       Impact factor: 5.157

6.  Two distinct conformations of a rinderpest virus epitope presented by bovine major histocompatibility complex class I N*01801: a host strategy to present featured peptides.

Authors:  Xin Li; Jun Liu; Jianxun Qi; Feng Gao; Qirun Li; Xiaoying Li; Nianzhi Zhang; Chun Xia; George F Gao
Journal:  J Virol       Date:  2011-03-30       Impact factor: 5.103

7.  A Novel MHC-I Surface Targeted for Binding by the MCMV m06 Immunoevasin Revealed by Solution NMR.

Authors:  Nikolaos G Sgourakis; Nathan A May; Lisa F Boyd; Jinfa Ying; Ad Bax; David H Margulies
Journal:  J Biol Chem       Date:  2015-10-13       Impact factor: 5.157

8.  Adoptive Transfer of mRNA-Transfected T Cells Redirected against Diabetogenic CD8 T Cells Can Prevent Diabetes.

Authors:  Sigal Fishman; Mark D Lewis; L Khai Siew; Evy De Leenheer; Dimitri Kakabadse; Joanne Davies; Doron Ziv; Alon Margalit; Nathan Karin; Gideon Gross; F Susan Wong
Journal:  Mol Ther       Date:  2017-01-18       Impact factor: 11.454

9.  A potential role for shed soluble major histocompatibility class I molecules as modulators of neurite outgrowth.

Authors:  Lorraine R Washburn; Dan Zekzer; Shoshana Eitan; Yuxin Lu; Hoa Dang; Blake Middleton; Christopher J Evans; Jide Tian; Daniel L Kaufman
Journal:  PLoS One       Date:  2011-03-31       Impact factor: 3.240

10.  Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo.

Authors:  Serhat Erbayraktar; Giovanni Grasso; Alessandra Sfacteria; Qiao-wen Xie; Thomas Coleman; Mads Kreilgaard; Lars Torup; Thomas Sager; Zubeyde Erbayraktar; Necati Gokmen; Osman Yilmaz; Pietro Ghezzi; Pia Villa; Maddalena Fratelli; Simona Casagrande; Marcel Leist; Lone Helboe; Jens Gerwein; Søren Christensen; Marie Aavang Geist; Lars Østergaard Pedersen; Carla Cerami-Hand; Jean-Paul Wuerth; Anthony Cerami; Michael Brines
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-13       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.